Skip to main content

Hepion Pharmaceuticals, Inc. insider trading

HEPAOTC
$0.08-0.02 (-17.50%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+25.0%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • VSVincent S. LoPrioreExecutive Chairman33.8065%of company
  • BGBlack Global 5 LLC10% Owner11.0841%of company
  • KHKI Holdings, Ltd.10% Owner11.0841%of company
  • SASireesh AppajosyulaChief Operating Officer3.6023%of company
  • MJMichael J. PurcellDirector3.6023%of company
  • GSGary S. StetzInterim CEO3.6023%of company
  • CLChase LoPrioreVP, Corp. Dev.1.3855%of company
  • GSGary S. Stetz IIDirector0.5542%of company
  • DFDanina FisherDirector0.2217%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
HEPADanina FisherDirectorOpen market purchase$10KNot reported$0.05$10KSep 29, 2026Oct 2, 2026
HEPAGary S. Stetz IIDirectorOpen market purchase$25KNot reported$0.05$25KAug 3, 2026Aug 12, 2026
HEPAGary S. StetzInterim CEOOpen market purchase$100K+160.0%$0.05$100KAug 3, 2026Aug 12, 2026
HEPAMichael J. PurcellDirectorOpen market purchase$100K+160.0%$0.05$100KAug 3, 2026Aug 12, 2026
HEPASireesh AppajosyulaChief Operating OfficerOpen market purchase$100K+160.0%$0.05$100KAug 3, 2026Aug 12, 2026
HEPAVincent S. LoPrioreExecutive ChairmanOpen market purchase$100K+7.0%$0.05$100KAug 3, 2026Aug 12, 2026
HEPAVincent S. LoPrioreExecutive ChairmanOpen market purchase$400K+35.6%$0.05$400KAug 3, 2026Aug 12, 2026
HEPAMichael J. PurcellDirectorOpen market purchase$50KNot reported$0.04$50KApr 21, 2026Apr 27, 2026
HEPAVincent S. LoPrioreExecutive ChairmanOpen market purchase$50K+12.5%$0.04$50KApr 21, 2026Apr 27, 2026
HEPAVincent S. LoPrioreExecutive ChairmanOpen market purchase$200K+80.0%$0.04$200KApr 21, 2026Apr 27, 2026
HEPASireesh AppajosyulaDirectorOpen market purchase$50KNot reported$0.04$50KApr 21, 2026Apr 27, 2026
HEPAGary S. StetzInterim CEOOpen market purchase$50KNot reported$0.04$50KApr 21, 2026Apr 27, 2026
End of history · 12 transactions
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.